Efficacy and safety of a new antiepileptic drug lacosamide in patients with focal epilepsy: data of double-blind placebo controlled trials

Mil'chakova L.E.; Gekht A.B.

doi:https://doi.org/

Mil'chakova L.E.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Gekht A.B.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

SPIN RSCI: 7691-3288
Scopus AuthorID: 7003326363
ResearcherID: Y-6725-2018
ORCID: 0000-0002-1170-6127

Efficacy and safety of a new antiepileptic drug lacosamide in patients with focal epilepsy: data of double-blind placebo controlled trials

Authors:

Mil'chakova L.E., Gekht A.B.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(3‑2): 39‑43

Read: 3330 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Mil'chakova LE, Gekht AB. Efficacy and safety of a new antiepileptic drug lacosamide in patients with focal epilepsy: data of double-blind placebo controlled trials. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(3‑2):39‑43. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Ring chromosome 14 syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10-2):96-102

Stereo-EEG-guided radiofrequency thermocoagulations in drug-resistant focal epilepsy. Burdenko's Journal of Neurosurgery. 2025;(3):7-16

Abstract:

Keywords:

lacosamide

focal epilepsy

resistant epilepsy

polytherapy

Authors:

Mil'chakova L.E.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Gekht A.B.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

SPIN RSCI: 7691-3288
Scopus AuthorID: 7003326363
ResearcherID: Y-6725-2018
ORCID: 0000-0002-1170-6127

Close metadata

References:

Gusev E.I., Burd G.S., Gekht A.B. i dr. Epilepsiya u bol'nykh ishemicheskoi bolezn'yu golovnogo mozga. Zhurn nevrol i psikhiat 1997; 97:8.
Gusev E.I., Belousov Yu.B., Gekht A.B. i dr. Lechenie epilepsii: ratsional'noe dozirovanie antikonvul'santov. St-Peterburg 1999;11-15.
Annegers J.F., Hauser W.A., Elveback L.R. Remission of seizures and relapse in patients with epilepsy. Epilepsia 1979;20:729-737.
Ben-Menachem E., Biton V., Jatuzis D. et al. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 2007;48:1308-1317.
Bialer M. New antiepileptic drugs currently in clinical trials: is there a strategy in their development? Ther Drug Monit 2002;24:85-90.
Bialer M., Johannessen S.I., Kupferberg H.J. et al. Progress report on new antiepileptic drugs: a summary of the Eighth Eilat Conference (EILAT VIII). Epil Res 2007;73:1-5.
Brodie M.J., Kwan P. Staged approach to epilepsy management. Neurology 2002;58:Suppl 5:S2-S8.
Cawello W., Kropeit D., Schiltmeyer B. et al. Food does not affect the pharmacokinetics of SPM 927. Epilepsia 2004;45:Suppl 7:307:Abstr 2.342.
Chung S., Sperling M., Biton V. et al. and the SP745 Study Group. Lacosamide: Efficacy and Safety as Oral Adjunctive Treatment in Adults with Partial Onset Seizures. Poster Presentation, 11th EFNS. Brussels 2007.
Cockerell O.C., Johnson A.L., Sander J.W., Shorvon S.D. Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study. Epilepsia 1997;38:1:31-46.
Cramer J.A. Quality of life and compliance. In: Epilepsy and Quality of Life. Eds. M.R. Trimble, W.E. Dodson. New York: Raven Press 1994.
Devinsky Orrin M.D. Quality of life with epilepsy. In: Treatment of Epilepsy: Principles and Practice, 2nd ed. Baltimore: Elanie Wyllie 1996.
Doty P., Rudd G.D., Stoehr T., Thomas D. Lacosamide. Neurotherapeutics 2007;4:145-148.
Errington A.C., Coyne L., Stchr T. et al. Seeking a mechanism of action for the novel anticonvulsant lacosamide. Neuropharmacology 2006;50:1016-1029.
Errington A.C., Stchr T., Heers C., Lees G. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol 2008;73:157-169.
Freitag J.M., Beyreuther B., Heers C., Stoehr T. Lacosamide modulates collapsin response mediator protein 2 (CRMP-2). Epilepsia 2007;48:320.
Goodridge D.M., Shorvon S.D. Epileptic seizures in a population of 6000. I: Demography, diagnosis and classification, and role of the hospital services. Br Med J 1983;287:6393:641-644.
Guberman A., Bruni J. Essentials of clinical epilepsy. Second Edition. 2000;100.
Guekht A.B., Mitrokhina T.V., Lebedeva A.V. et al. Factors influencing on quality of life in people with epilepsy. Seizure 2007;16:2:128-133.
Halasz P., Rosenow F., Kalviainen R. et al. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial. Epilepsia 2009;50:3:443-453.
Halford J., Lapointe M. Clinical perspective on lacosamide. Epilepsia Curr 2009;9:1:1-9.
Horstmann R., Bonn R., Cawello W. et al. Basic clinical pharmacological investigations of the new antiepileptic drug SPM 927 (Abstract 2.174). Epilepsia 2002;43:Suppl 7:188.
Horstmann R., Bonn R., Cawello W. et al. SPM 927 does not interact with valproic acid and carbamazepine (Abstract 1.271). Epilepsia 2003;44:Suppl 9:97.
Kropeit D., Scharfenecker U., Schiltmeyer B. et al. Lacosamide has low potential for drug-drug interaction (Abstract 851). J Pain 2006;7:S63.
Kwan P., Brodie M.J. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-319.
Rosenfeld W., Fountain N.B., Kaubrys G. et al. Lacosamide: an interim evaluation of long-term safety and efficacy as oral adjunctive therapy in subjects with partial-onset seizures. Epilepsia 2007;48:Suppl 6:318-319.
Rosenfeld W., Fountain N.B., Kaubrys G. et al. Lacosamide: an interim evaluation of long-term safety and efficacy as oral adjunctive therapy in subjects with partial-onset seizures. Poster presented at 61st Annual Meeting of the American Epilepsy Society (AES). Philadelphia (USA) 2007.
Sheets P.L., Heers C., Stoehr T., Cummins T.R. Differential block of sensory neuronal voltage-gated sodium channels by lacosamide, lidocaine and carbamazepine. J Pharmacol Exp Ther 2008;326:89-99.
Thomas D., Horstmann R., Scharfenecker U. et al. Lacosamide has low potential for drug-drug-interaction. Poster presented at: The American Society of Consultant Pharmacists 38th Annual Meeting. Philadelphia 2007.